Antiplatlets Flashcards
P2y12 receptor inhibitors …main site for ADP binding on platlet cell
Clopidogrel
Ticlopidine
Ticagrelor
Prasugrel
Gp2a3b inhibitors
Tirofiban
Eptifibatide
Phosphodiesterase 3 INnhibitors
Dipyridamole
Cylostazol
Medication that work via platelet plug formation (antiplatlets)
P2y12 receptor inhibitors (clopidogrel,prasugrel,ticagrelor)
Gp3a2b receptor inhibitors (tirofiban,Eptifibatide)
Pde-3 inhibitors (dipyridamole)
Cox inhibitors (aspirin, nsaids)
Heparin mechanism of action
stimulates antithrombin III -which prevents the activation of II, VII, IX, X, XI, XII
Heparin agents and moa
STIMULATES ANTITHROMBIN III
Heparin.- stimulates antithrobin III -(inhibits x and Ii)
LMWH - inhibits X>II
ULtra LMWH - fondaparinux - inhibits X
Factor 10a inhibitors
Apixaban (Eliquis)
Rivaroxaban (Xarelto)
Edoxaban
Direct Thrombin Inhibitors
Dabigatran (oral)
Bivalirudun
Argatroban
Doac (direct oral anticoagulants)
Direct thrombin inhibitors -dabigatran
Factor 10a inhibitors - apixaban, rivaroxaban, edoxaban
Vitamin k antagonist -(vit k epoxide reductive inhibitor) prevent vit k from being in reduced form which doesn’t activate GGT then activation II, VII,Ix, X)
Warfarin
Clopidogrel
P2y12 receptor inhibitors (plavix)
Prasugrel
P2y12 receptor inhibitors (Efient)
Ticagular
P2y12 receptor inhibitors (Brilinta)
RIVAROXABAN
XARELTO - factor10a inhibitors
Apixaban
Eliquis Factor 10a inhibitors
Argatroban
Novastan. Direct thrombin inhibitor -Used for heparin induced thrombocytopenia
Bivalirubin
Direct thrombin inhibitor (potential benefit in pediatric ecmo cases - reduction in transfusion requirements)
Dabigatran
Pradexa - oral direct thrombin inhibitor
Dabigatran
Pradexa
Dabigatran antidote
Idarucizumab
Fibrinolytics mechanism of action
converts of plasminagen to plasmin via tissue plasminagen activator - breaks clot
Drugs which increase TPA -
Altaplase
Retroplase
Tenectaplase
Urokinase
Streptokinase